oncology
Breast Cancer

Surgery not beneficial in de novo stage IV breast cancer

Adding in locoregional treatment (LRT) to optimal systemic treatment does not improve overall survival in women who present with de novo stage IV breast cancer and an intact primary tumour. Professor Seema Khan, a breast cancer surgeon from Northwestern Medicine in Chicago, presented the findings of the ECOG-ACRIN study 2108 to the ASCO20 Virtual Scientific ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic